Stimulant and Risperidone in Children With Severe Physical Aggression.

Trial Profile

Stimulant and Risperidone in Children With Severe Physical Aggression.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2017

At a glance

  • Drugs Methylphenidate (Primary) ; Risperidone (Primary)
  • Indications Aggression; Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Acronyms TOSCA
  • Most Recent Events

    • 01 Dec 2017 Results assessing clinical implications of the treatment, published in the Journal of the American Academy of Child and Adolescent Psychiatry
    • 01 Jun 2016 Primary endpoint has been met. (NCBRF-TIQ D-Total Score), as per an article published in the Journal of the American Academy of Child and Adolescent Psychiatry.
    • 01 Jun 2016 52-week results (n= 108) published in the Journal of the American Academy of Child and Adolescent Psychiatry
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top